ATE225185T1 - Verfahren zur behandlung von allergischem asthma - Google Patents

Verfahren zur behandlung von allergischem asthma

Info

Publication number
ATE225185T1
ATE225185T1 AT96926134T AT96926134T ATE225185T1 AT E225185 T1 ATE225185 T1 AT E225185T1 AT 96926134 T AT96926134 T AT 96926134T AT 96926134 T AT96926134 T AT 96926134T AT E225185 T1 ATE225185 T1 AT E225185T1
Authority
AT
Austria
Prior art keywords
allergic asthma
treating allergic
treating
asthma
allergic
Prior art date
Application number
AT96926134T
Other languages
English (en)
Inventor
Robert B Fick Jr
Paula M Jardieu
Monika B Schoenhoff
Steven J Shire
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24021032&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE225185(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Genentech Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of ATE225185T1 publication Critical patent/ATE225185T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39591—Stabilisation, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT96926134T 1995-07-27 1996-07-24 Verfahren zur behandlung von allergischem asthma ATE225185T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50801495A 1995-07-27 1995-07-27
PCT/US1996/012275 WO1997004807A1 (en) 1995-07-27 1996-07-24 Methods for treatment of allergic asthma

Publications (1)

Publication Number Publication Date
ATE225185T1 true ATE225185T1 (de) 2002-10-15

Family

ID=24021032

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96926134T ATE225185T1 (de) 1995-07-27 1996-07-24 Verfahren zur behandlung von allergischem asthma

Country Status (16)

Country Link
EP (1) EP0841946B2 (de)
JP (1) JP4153560B2 (de)
CN (2) CN101172099B (de)
AR (1) AR003468A1 (de)
AT (1) ATE225185T1 (de)
AU (1) AU715338B2 (de)
CA (1) CA2226624C (de)
DE (1) DE69624116T3 (de)
DK (1) DK0841946T4 (de)
ES (1) ES2186796T5 (de)
IL (1) IL122733A (de)
MX (1) MX9800760A (de)
PT (1) PT841946E (de)
RU (1) RU2229288C2 (de)
WO (1) WO1997004807A1 (de)
ZA (2) ZA966075B (de)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6685940B2 (en) 1995-07-27 2004-02-03 Genentech, Inc. Protein formulation
US6267958B1 (en) 1995-07-27 2001-07-31 Genentech, Inc. Protein formulation
US6991790B1 (en) 1997-06-13 2006-01-31 Genentech, Inc. Antibody formulation
US6171586B1 (en) 1997-06-13 2001-01-09 Genentech, Inc. Antibody formulation
US6630140B1 (en) * 1998-03-10 2003-10-07 The Children's Hospital Of Philadelphia Compositions and methods for treatment of asthma
US6299875B1 (en) * 1998-06-04 2001-10-09 Panacea Pharmaceuticals, Llc Methods to block IGE binding to cell surface receptors of mast cells
US6913749B2 (en) 1998-11-02 2005-07-05 Resistentia Pharmaceuticals Ab Immunogenic polypeptides for inducing anti-self IgE responses
US8703126B2 (en) 2000-10-12 2014-04-22 Genentech, Inc. Reduced-viscosity concentrated protein formulations
JP4340062B2 (ja) * 2000-10-12 2009-10-07 ジェネンテック・インコーポレーテッド 粘度の減少した濃縮タンパク質製剤
EP2284192A3 (de) 2002-11-08 2011-07-20 Ablynx N.V. Antikörper aus Camelidae zur sublingualen Verabreichung
EP1558647B1 (de) 2002-11-08 2015-06-10 Ablynx N.V. Einzeldomaene antikörpern gegen tnf-alpha und ihre verwendungen
JO3000B1 (ar) 2004-10-20 2016-09-05 Genentech Inc مركبات أجسام مضادة .
DE202006020194U1 (de) * 2006-03-01 2007-12-06 Bioceuticals Arzneimittel Ag G-CSF-Flüssigformulierung
NZ577858A (en) * 2007-01-29 2012-02-24 Valtion Teknillinen Method for producing novel ige based reagents
AR065368A1 (es) 2007-02-15 2009-06-03 Astrazeneca Ab Anticuerpos para moleculas de ige
EP2052736A1 (de) * 2007-10-26 2009-04-29 Nycomed Danmark ApS Parathyroidhormon-Formulierungen und ihre Verwendungen
AU2008340304B2 (en) * 2007-12-21 2016-03-03 Aptevo Biotherapeutics Llc Stabilized factor IX formulations containing trehalose
ES2511844T3 (es) * 2007-12-21 2014-10-23 F. Hoffmann-La Roche Ag Formulación de anticuerpo
HUE054585T2 (hu) 2008-04-29 2021-09-28 Ascendis Pharma Endocrinology Div A/S Pegilezett rekombináns humán növekedési hormon vegyületek
KR101593285B1 (ko) * 2008-10-29 2016-02-11 아블린쓰 엔.브이. 단일 도메인 항원 결합 분자의 제형
CA2739352C (en) 2008-10-29 2021-07-13 Wyeth Llc Methods for purification of single domain antigen binding molecules
CA2783296C (en) 2009-12-15 2019-01-15 Ascendis Pharma As Growth hormone composition
EP4450523A3 (de) 2010-04-02 2025-03-12 Amunix Pharmaceuticals, Inc. Bindungsfusionsproteine, bindungsfusionsprotein-arzneimittelkonjugate, xten-arzneimittelkonjugate sowie verfahren zur herstellung und verwendung davon
CN102533704A (zh) * 2010-12-30 2012-07-04 上海雅心生物技术有限公司 即配即用型的胰蛋白酶制剂
MX341076B (es) * 2011-03-31 2016-08-04 Merck Sharp & Dohme Formulaciones estables de anticuerpos para el receptor humano pd-1 de meurte programada y tratamientos relacionados.
CA2853112C (en) * 2011-10-25 2018-08-21 Onclave Therapeutics Limited Antibody formulations and methods
BR112016006455A2 (pt) * 2013-09-27 2017-08-01 Hanmi Pharm Ind Co Ltd ?formulação de conjugado de hormônio de crescimento humano de ação prolongada?
CN104707146B (zh) * 2013-12-16 2019-04-16 浙江海正药业股份有限公司 一种含有阿达木单抗的药物组合物
ES2947818T3 (es) 2014-11-18 2023-08-21 Ascendis Pharma Endocrinology Div A/S Nuevos profármacos poliméricos de la HCh
ES2896971T3 (es) 2014-11-21 2022-02-28 Ascendis Pharma Endocrinology Div A/S Formas de administración de hormona del crecimiento de acción prolongada
GB201610198D0 (en) 2016-06-10 2016-07-27 Ucb Biopharma Sprl Anti-ige antibodies
RU2019138507A (ru) 2017-05-02 2021-06-02 Мерк Шарп И Доум Корп. Составы антител против lag3 и совместные составы антител против lag3 и антител против pd-1
JOP20190260A1 (ar) 2017-05-02 2019-10-31 Merck Sharp & Dohme صيغ ثابتة لأجسام مضادة لمستقبل الموت المبرمج 1 (pd-1) وطرق استخدامها
PL3639845T3 (pl) * 2017-07-25 2023-10-23 Jiangsu Hengrui Medicine Co., Ltd. Kompozycja farmaceutyczna zawierająca kompleks białka il-15 i jej zastosowania
KR20230142806A (ko) * 2018-02-09 2023-10-11 제넨테크, 인크. 비만 세포 매개 염증성 질환에 대한 치료 및 진단 방법
CN110732023B (zh) * 2018-07-18 2023-06-16 江苏恒瑞医药股份有限公司 一种her2抗体药物组合物及其用途
CN120842406A (zh) 2018-10-31 2025-10-28 默沙东有限责任公司 抗人pd-1抗体晶体及其使用方法
EP3934625A1 (de) 2019-03-04 2022-01-12 Ascendis Pharma Endocrinology Division A/S Langwirkende wachstumshormon-darreichungsformen mit überlegener wirksamkeit gegenüber täglichem somatropin
CN113827717A (zh) * 2020-06-23 2021-12-24 三生国健药业（上海）股份有限公司 抗her2单克隆抗体冻干制剂及制备方法
JP2023541217A (ja) 2020-07-10 2023-09-29 シャンハイ ジェミンケア ファーマシューティカル カンパニー，リミティド 抗ＩｇＥ改変抗体及びその適用
TW202409078A (zh) * 2022-07-18 2024-03-01 中國大陸商蘇州創勝醫藥集團有限公司 穩定之包含抗gremlin1抗體的藥物製劑

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3729863A1 (de) * 1987-09-05 1989-03-16 Boehringer Mannheim Gmbh Stabilisierte erythropoietin-lyophilisate
AU616916B2 (en) * 1987-11-20 1991-11-14 Kissei Pharmaceutical Co. Ltd. 4h-quinolizin-4-one compounds exhibiting therapeutic activities
DE122006000007I2 (de) * 1987-12-31 2008-03-27 Tanox Inc -tragenden b-lymphocyten befinden.
US5011676A (en) * 1990-03-27 1991-04-30 Thomas Jefferson University Method to directly radiolabel antibodies for diagnostic imaging and therapy
US5290764A (en) * 1992-01-14 1994-03-01 The Dupont Merck Pharmaceutical Company Stabilization of active plasminogen activator inhibitor-1
AU3923293A (en) * 1992-03-20 1993-10-21 Immunet Human monoclonal antibodies and methods for human monoclonal antibody production
JPH07118168A (ja) * 1993-10-19 1995-05-09 Tomoyasu Ra ＩｇＥ産生抑制剤
PT589840E (pt) * 1992-09-24 2004-08-31 Tanox Biosystems Inc Anticorpos monoclonais reformulados contra um isotipo de imunoglobulina
DE4344824C1 (de) * 1993-12-28 1995-08-31 Immuno Ag Hochkonzentriertes Immunglobulin-Präparat und Verfahren zu seiner Herstellung
FR2719479B1 (fr) * 1994-05-04 1996-07-26 Sanofi Elf Formulation stable lyophilisée comprenant une protéine: kit de dosage.

Also Published As

Publication number Publication date
IL122733A0 (en) 1998-08-16
ZA966240B (en) 1998-01-23
CN101172100A (zh) 2008-05-07
AU6638196A (en) 1997-02-26
CA2226624C (en) 2013-07-16
EP0841946B1 (de) 2002-10-02
ES2186796T5 (es) 2009-04-01
JP4153560B2 (ja) 2008-09-24
MX9800760A (es) 1998-04-30
ZA966075B (en) 1998-01-19
CN101172099B (zh) 2012-02-15
RU2229288C2 (ru) 2004-05-27
JPH11510172A (ja) 1999-09-07
AU715338B2 (en) 2000-01-20
ES2186796T3 (es) 2003-05-16
DK0841946T4 (da) 2009-02-16
WO1997004807A1 (en) 1997-02-13
IL122733A (en) 2001-09-13
DE69624116D1 (de) 2002-11-07
DE69624116T2 (de) 2003-06-18
DK0841946T3 (da) 2003-02-10
AR003468A1 (es) 1998-08-05
EP0841946A1 (de) 1998-05-20
CN101172099A (zh) 2008-05-07
PT841946E (pt) 2003-02-28
DE69624116T3 (de) 2009-07-09
CA2226624A1 (en) 1997-02-13
EP0841946B2 (de) 2008-10-15

Similar Documents

Publication Publication Date Title
DE69624116D1 (de) Verfahren zur behandlung von allergischem asthma
DE69603838D1 (de) Verfahren zur behandlung von gasen
DE69625690D1 (de) Verfahren zur vorbeugung und behandlung von allergien
DE69701714D1 (de) Verfahren zur behandlung von glassubstraten
DE69425372D1 (de) Verfahren zur behandlung endo-ostealer materialien
DE69331469D1 (de) Verfahren zur behandlung von abfällen
DE69726289D1 (de) Verfahren und zusammensetzung zur behandlung von substraten bezüglich benetzbarkeit
DE69218202D1 (de) Verfahren zur behandlung von fluoroaluminosilikatgläsern
DE69529768D1 (de) Verfahren und herstellung zur hydroverwirrung von vliesstoffen
DE69426970D1 (de) Verfahren zur Behandlung einer Ölquelle
DE59504072D1 (de) Verfahren zur herstellung von esterquats
EP0820467A4 (de) Verfahren zur behandlung von augenkrankheiten
DE69507500D1 (de) Verfahren zur behandlung von kunststoffgiessformen
DE69918306T2 (de) Verfahren und vorrichtung zur behandlung von arrythmien
DE69624625D1 (de) Verfahren und Vorrichtung zur Behandlung von Organohalogenkomponenten
DE59810532D1 (de) Verfahren zur behandlung von cellulosischen formkörpern
DE69417018D1 (de) Verfahren zur behandlung von teilchenmaterial
DE69526796D1 (de) Verfahren zur inhibierung von pflanzenkrankheiten
ATE232919T1 (de) Zusammensetzung zur behandlung von wäsche sowie verfahren hierfür
DE69613446D1 (de) Verfahren zur Behandlung von wässerigem Strom
DE69814467D1 (de) Verfahren zur prophylaktischen behandlung von mastitis
DE69607604D1 (de) Verfahren zur herstellung von aminoethylethanolamin und/oder hydroxyethylpiperazin
DE69518824D1 (de) Verfahren zur behandlung von bremsscheiben
ATE371453T1 (de) Verfahren zur behandlung von okularen neovaskularen erkrankungen
DE69609082D1 (de) Verfahren zur behandlung von abfällen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0841946

Country of ref document: EP

UEP Publication of translation of european patent specification

Ref document number: 0841946

Country of ref document: EP